Cholteesupachai Jiranut, Buddhari Wacin, Udayachalerm Wasan, Chaipromprasit Jakrapun, Lertsuwunseri Vorarit, Kaewsukkho Patcharin, Boonyaratavej Smonporn, Srimahachota Suphot
Cardiac Center and Division of Cardiology, Department of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand.
J Med Assoc Thai. 2012 Jul;95(7):866-73.
Primary percutaneous coronary intervention (PCI) appears to be the preferred reperf usion methodfor patients with ST-segment elevation myocardial infarction (STEMI). This method was introduced in our hospital before the year 2000. In Thailand, data showing long experience results in patients with STEMI who underwent primary percutaneous coronary intervention remain limited.
To demonstrate 11-yr experience of primary percutaneous coronary intervention at King Chulalongkorn Memorial Hospital.
This retrospective descriptive single-center study analyses clinical characteristics, angiographic features and in-hospital outcomes of 772 patients with STEMI who underwent primary percutaneous coronary intervention between 2000 and 2010.
Seven hundred seventy two consecutive patients with STEMI were enrolled in the study. Three-fourth of the patients were male. Mean age was 60.13 years (range 28 to 96 years) and 12.6% were older than 75 years old. Forty-eight percent of patients were referred from hospital without cardiac catheterization facilities. Of these patients 94.4% underwent primary PCI and rescue PCI was done in 5.6% of patients. There were 27% ofpatients with left ventricular ejection fraction less than 40%, 21% of patients with Killip's class IV and 12% suffered cardiac arrest prior to angiography. Median door-to-balloon time in referred and non-referred patients was 28 and 104.5 minutes, respectively. Ninety-two percent of referred patients and 36% of non-referred patients, door to balloon time were within 90 minutes. About half ofthe patients had multi-vessels disease at that time of diagnosis. The overall angiographic success rate was 96%. Platelet glycoprotein llb/lla inhibitors were used in two-third ofpatients and stent placement in 82%. Post procedural thrombolysis in myocardial infarction (TII) 3 flow was documented in 87%. Intra-aortic balloon pump was used in 15% and thrombus aspiration device in 47%. During hospital stay, in-hospital mortality was 8.5% and 80% of those cases died from cardiac cause. One-third of patients died if they had Killip's class IV at presentation compared with 1.6% in patients with Killip's class I-III. In-hospital major adverse cardiovascular event was 10.4%.
During 11 years of primary PCI experience in King Chulalongkorn Memorial Hospital, the angiographic success rate was high with acceptable in-hospital mortality and major adverse cardiac event. This strategy of treatment should be the treatment of choice for patients with STEMI in experienced PCI capable center with 24 hours/7 days availability.
对于ST段抬高型心肌梗死(STEMI)患者,直接经皮冠状动脉介入治疗(PCI)似乎是首选的再灌注方法。该方法于2000年前引入我院。在泰国,关于STEMI患者接受直接经皮冠状动脉介入治疗的长期经验结果的数据仍然有限。
展示朱拉隆功国王纪念医院11年直接经皮冠状动脉介入治疗的经验。
这项回顾性描述性单中心研究分析了2000年至2010年间772例接受直接经皮冠状动脉介入治疗的STEMI患者的临床特征、血管造影特征和院内结局。
772例连续的STEMI患者纳入研究。四分之三的患者为男性。平均年龄为60.13岁(范围28至96岁),12.6%的患者年龄超过75岁。48%的患者是从没有心导管检查设备的医院转诊而来。这些患者中94.4%接受了直接PCI,5.6%的患者进行了补救性PCI。27%的患者左心室射血分数低于40%,21%的患者为Killip分级IV级,12%的患者在血管造影前发生心脏骤停。转诊患者和非转诊患者从入院到球囊扩张的中位时间分别为28分钟和104.5分钟。92%的转诊患者和36%的非转诊患者从入院到球囊扩张的时间在90分钟内。约一半的患者在诊断时患有多支血管病变。总体血管造影成功率为96%。三分之二的患者使用了血小板糖蛋白IIb/IIIa抑制剂,82%的患者进行了支架置入。术后心肌梗死溶栓(TIMI)3级血流记录为87%。15%的患者使用了主动脉内球囊泵,47%的患者使用了血栓抽吸装置。住院期间,院内死亡率为8.5%,其中80%的病例死于心脏原因。就诊时为Killip分级IV级的患者中有三分之一死亡,而Killip分级I - III级的患者中这一比例为1.6%。院内主要不良心血管事件发生率为10.4%。
在朱拉隆功国王纪念医院11年直接PCI经验中,血管造影成功率高,院内死亡率和主要不良心脏事件可接受。对于有经验的具备PCI能力且每周7天、每天24小时可用的中心,这种治疗策略应是STEMI患者的首选治疗方法。